| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Smith & Nephew plc (ADR)
| NYSE
|
SNN
|
59.57
|
|
+0.69
(1.17%)
| 10.79B
|
|
|
Smith & Nephew plc is a global medical devices business operating in the markets
for orthopaedic reconstruction and trauma, endoscopy (which includes ...
| |
| |
|
|
Smith & Nephew plc
| LON
|
SN
|
756.65
|
|
-1.35
(-0.18%)
| 6.84B
|
|
|
Smith & Nephew plc is a global medical devices business operating in the markets
for orthopaedic reconstruction and trauma, endoscopy (which includes ...
| |
| |
|
|
SMITH & NEPHEW PLC O
| OTCMKTS
|
SNNUF
|
11.65
|
|
-0.20
(-1.69%)
| 10.70B
|
|
|
|
|
|
SMITH+NEPHEW ADR5 DL-20/5
| FRA
|
NPWA
|
44.59
|
|
+0.33
(0.74%)
|
|
|
|
|
|
|
SMITH + NEP. DL -,20
| FRA
|
NPW1
|
8.84
|
|
+0.04
(0.43%)
|
|
|
|
|
|
|
Quest Diagnostics Inc
| NYSE
|
DGX
|
62.59
|
|
-0.03
(-0.05%)
| 9.89B
|
|
|
Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic
testing, information and services, providing insights that enable patients ...
| |
| |
|
|
Nanosphere, Inc.
| NASDAQ
|
NSPH
|
3.72
|
|
+0.19
(5.38%)
| 208.66M
|
|
|
Nanosphere, Inc. develops, manufactures and markets a molecular diagnostics
platform, the Verigene System. The Company's nanoparticle technology provides
...
| |
| |
|
|
Tetraphase Pharmaceuticals Inc
| NASDAQ
|
TTPH
|
7.94
|
|
+0.06
(0.76%)
| 157.75M
|
|
|
... use as a first-line empiric monotherapy for the treatment of multi-drug
resistant infections, including multi-drug resistant Gram-negative infections.
| |
| |
|
|
QUEST DIAGNOSTICS DL-,01
| FRA
|
QDI
|
46.78
|
|
-0.26
(-0.55%)
|
|
|
|
|
|
|
NANOSPHERE INC. DL-,01
| FRA
|
3NS
|
2.75
|
|
-0.04
(-1.29%)
|
|
|
|
|
|
|
TETRAPHASE PHTCLS DL-,001
| FRA
|
7TP
|
5.90
|
|
+0.04
(0.61%)
|
|
|
|
|
|
